InvestorsHub Logo
Followers 8
Posts 2018
Boards Moderated 0
Alias Born 07/19/2006

Re: gr8db8 post# 699

Monday, 03/20/2017 10:37:03 PM

Monday, March 20, 2017 10:37:03 PM

Post# of 2099
Me too, but with one caveat. If it works well in rGBM, why wouldn't Roche simply buy it, expanding indications of Avastin with a potential combination approach in different solid tumors. Keep in mind that Avastin is not approved in Europe for rGBM, but VB-111 might alter that reality. Roche might wish to fund several studies combining the two in different solid tumors.

I hope it remains a stand alone company as well, but I think solid rGBM news could lead to a buyout. Just MHO. On the other hand, the company might simply partner with Roche for royalties.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News